Boryung, traditionally known for its pharma business, said it would establish a joint venture (JV) with Axiom Space, a U.S.-based space infrastructure developer, in Korea to invest in healthcare in space."We agreed to establish a JV with Axiom Space on Monday," Boryung CEO Jay Kim said at the compan
GC said it has won a $43.38 million contract with Pan American Health Organization (PAHO) to supply its influenza vaccine to Latin America.The vaccines will be supplied to Latin American countries in the first half of the year.With the latest bidding win, GC maintained the top market share position
Over the past decade, PARP inhibitors have emerged as the main trend in the ovarian cancer treatment market. And two drugs -- Lynparza (olaparib) and Zejula (niraparib) -- divide the market.First runner Lynparza drew attention by treating patients with specific genetic mutations. In contrast, lateco
In the contracted drug quantity, a yardstick of the prescription rate by Seoul National University Hospital (SNUH), GSK’s HIV treatment Dovato (dolutegravir/lamivudine) has surpassed Gilead’s Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide, B/F/TAF).According to the integrated bidding anno
Prestige Biopharma said on Thursday that its new pancreatic cancer antibody drug candidate, PBP1510, (ingredient: ulenistamab), was granted FDA Fast Track designation.PBP1510 specifically binds to PAUF and exerts anti-metastasis and immune modulation effects. Pancreatic cancer generally expresses a
Biopharma companies with GLP-1 (glucagon-like peptide-1) analogs, which have become a new trend in the obesity treatment market long dominated by appetite suppressants and fat-absorbance inhibitors, are upgrading their treatments.One of the latest GLP-1 analogs under development is drawing particula
Hanmi Pharmaceutical said it plans to participate in the 2023 BIO-Europe Spring Conference, where it will kick off its CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) business in earnest.By synergizing its development capabilities accumulated
Pfizer Korea’s 2022 sales exceeded 3 trillion won ($2.28 billion), nearly doubling the revenue volume from the previous year, thanks to the Covid-19 vaccine and treatment supply during the pandemic. According to an audit report submitted by the company to the Financial Supervisory Service on March 6
KAIST said on Thursday that its researchers have optimized an AI-based drug-drug interaction (DDI) platform to predict potential adverse reactions of drugs using Paxlovid as an example.The research team, led by Professor Lee Sang-yup at the Department of Chemical and Biomolecular Engineering (BK21 f
HealthBiome said that its HB03 anticancer microbiome drug obtained domestic patents for the administration of the anticancer microbiome alone or in combination with chemo or immuno-oncology drugs across multiple carcinomas on Friday.HealthBiome is a start-up company of the Korea Institute of Biotech
Korean biopharmaceutical companies are again heading to the annual Association for Cancer Research (AACR) conference to present their next-generation pipelines and platform technologies.This year's AACR event will be held in Orlando, Florida, from April 14-19. AACR is a global oncology organization
Liztox, a botulinum toxin product of Huons BiopharmaHuons Biopharma has received approval from the Ministry of Food and Safety for the phase 3 IND clinical trial of its Liztox (Hutox in the export name), a botulinum toxin (BTX) product treating benign masseteric hypertrophy (square jaw).The company
Hankook Korus Pharm, a Korean biopharma, said Wednesday its affiliate GL Rapha visited Saudi Arabia to discuss with the local government ministries and organizations about promoting a biopharmaceutical project in the country.The visit was organized at the request of the Saudi government, and Hankook
Prosecutors have indicted six botulinum toxin (BTX) manufacturers - Medytox, Hugel, Pharma Research Bio, Jetema, Korea BNC, and Korea BMI - for allegedly selling BTX injections without authorization.According to the Seoul Western District Prosecutors' Office on Wednesday, the prosecutors indicted th
A recent study said that although generic drugs offer the same effect and quality as original drugs, Korean consumers still have low trust in generics. As defined by the FDA, a generic drug is a medication created to be the same as an existing original drug in dosage, safety, strength, route of admi
Samsung Medical Center (SMC) said on Monday that its researchers have published a study showing shingles vaccination to patients before kidney transplantation can effectively prevent the occurrence of shingles after transplantation.This is the first time that the herpes zoster vaccine before transpl
LG Chem said Tuesday that it participated in a UNICEF tender and won a $200 million contract to supply Eupolio, its polio vaccine, and Eupenta, a multivalent vaccine that treats diphtheria, tetanus, pertussis, hepatitis B, meningitis.Under the contract, LG Chem will supply $100 million worth of Eupo
Keytruda (pembrolizumab), which lost the market leadership to Opdivo (nivolumab) in gastric cancer treatment due to the failure of the KEYNOTE-062 study in 2019, has made a splendid comeback with the success of the KEYNOTE-859 study.Professor Rha Sun-young of Yonsei Cancer Center conducted a success
Celltrion signed a joint R&D contract with Genuv to discover antibodies for new drug development. (Credit: Celltrion)Celltrion said on Tuesday it has signed a joint research and development contract with Genuv, a local drug developer, to discover antibodies for new drug development.Under the agreeme
Boryung said it will launch Finjuve Spray (ingredient: finasteride), the first spray-type finasteride hair loss drug in Korea, on March 21.The launch comes after the company secured the exclusive rights for Finjuve Spray from Almirall, a Spain-based pharmaceutical company, in January last year.It ob